Skip to main navigation menu Skip to main content Skip to site footer

Clinical Research

Vol 8 No 2 (2023): December

Combination of Irisin, Uric Acid, and Pro-Inflammatory Cytokine To Distinguish Gout Patients From Healthy Controls in The Governorate of Thi-Qar

(*) Corresponding Author
September 6, 2023


This study aimed to investigate the potential of combining uric acid levels with pro-inflammatory cytokines, specifically interleukin-1β (IL-1β) and the myokine irisin, to enhance the precision of gout diagnosis. The patient group comprised 80 individuals with gout, while the control group included 70 healthy subjects. Serum levels of IL-1β and irisin were measured in both groups, and Pearson correlation analysis was employed to assess their relationships with serum uric acid. Results revealed that gout patients exhibited significantly higher levels of IL-1β and serum uric acid but lower irisin levels compared to the control group. Negative correlations were observed between irisin and IL-1β, as well as between irisin and uric acid. Conversely, a positive correlation was found between serum uric acid and IL-1β. Receiver operating characteristic (ROC) curve analysis demonstrated high diagnostic accuracy for both IL-1β and irisin in discriminating gout patients from healthy individuals, suggesting their potential utility as diagnostic indicators for gout. This study underscores the promise of combining IL-1β, irisin, and uric acid measurements to enhance the accuracy of gout diagnosis, paving the way for further multicenter trials to validate this approach's effectiveness.


  • Novel Diagnostic Approach: This study proposes a novel diagnostic approach for gout by combining serum levels of uric acid with pro-inflammatory cytokines IL-1β and myokine irisin, demonstrating its potential to enhance precision.
  • Correlation Insights: The study reveals significant correlations between uric acid, IL-1β, and irisin levels, shedding light on the intricate relationship between inflammation, myokines, and gout pathophysiology.
  • Diagnostic Accuracy: High diagnostic accuracy, as indicated by ROC curve analysis, underscores the clinical utility of IL-1β and irisin as potential indicators for gout diagnosis, offering a promising avenue for improved clinical assessment.

Keywords: Gout Diagnosis, Interleukin-1β, Irisin, Uric Acid, Pro-Inflammatory Cytokines.


  1. C. Dhanasekar dan M. Rasool, "Morin, a dietary bioflavonol suppresses monosodium urate crystal-induced inflammation in an animal model of acute gouty arthritis with reference to NLRP3 inflammasome, hypo-xanthine phospho-ribosyl transferase, and inflammatory mediators," Eur. J. Pharmacol., vol. 786, hal. 116–127, 2016.
  2. C.-F. Kuo, M. J. Grainge, C. Mallen, W. Zhang, dan M. Doherty, "Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study," Ann. Rheum. Dis., vol. 74, hal. 661–667, 2015.
  3. G. Singh, B. Lingala, dan A. Mithal, "Gout and hyperuricaemia in the USA: prevalence and trends," Rheumatology, vol. 58, hal. 2177–2180, 2019.
  4. A. K. So dan F. Martinon, "Inflammation in gout: mechanisms and therapeutic targets," Nat. Rev. Rheumatol., vol. 13, hal. 639–647, 2017.
  5. A. Dumusc dan A. So, "Interleukin-1 as a therapeutic target in gout," Curr. Opin. Rheumatol., vol. 27, hal. 156–163, 2015.
  6. P. P. Khanna et al., "Treatment of acute gout: a systematic review," in Seminars in arthritis and rheumatism, vol. 44, hal. 31–38, Elsevier, 2014.
  7. A. So, A. Dumusc, dan S. Nasi, "The role of IL-1 in gout: from bench to bedside," Rheumatology, vol. 57, hal. i12–i19, 2018.
  8. L. A. B. Joosten, T. O. Crişan, P. Bjornstad, dan R. J. Johnson, "Asymptomatic hyperuricaemia: a silent activator of the innate immune system," Nat. Rev. Rheumatol., vol. 16, hal. 75–86, 2020.
  9. F. Martinon, V. Pétrilli, A. Mayor, A. Tardivel, dan J. Tschopp, "Gout-associated uric acid crystals activate the NALP3 inflammasome," Nature, vol. 440, hal. 237–241, 2006.
  10. L. A. B. Joosten et al., "Inflammatory arthritis in caspase 1 gene–deficient mice: contribution of proteinase 3 to caspase 1–independent production of bioactive interleukin‐1β," Arthritis Rheum. Off. J. Am. Coll. Rheumatol., vol. 60, hal. 3651–3662, 2009.
  11. L. B. E. Kienhorst et al., "Gout Is a Chronic Inflammatory Disease in Which High Levels of Interleukin‐8 (CXCL8), Myeloid‐Related Protein 8/Myeloid‐Related Protein 14 Complex, and an Altered Proteome Are Associated With Diabetes Mellitus and Cardiovascular Disease," Arthritis Rheumatol., vol. 67, hal. 3303–3313, 2015.
  12. J. Brenmoehl et al., "Irisin is elevated in skeletal muscle and serum of mice immediately after acute exercise," Int. J. Biol. Sci., vol. 10, hal. 338, 2014.
  13. T. Hofmann, U. Elbelt, dan A. Stengel, "Irisin as a muscle-derived hormone stimulating thermogenesis–a critical update," Peptides, vol. 54, hal. 89–100, 2014.
  14. J. A. Timmons et al., "Is irisin a human exercise gene?," Nature, vol. 488, hal. E9–E10, 2012.
  15. K. Hee Park et al., "Circulating irisin in relation to insulin resistance and the metabolic syndrome," J. Clin. Endocrinol. Metab., vol. 98, hal. 4899–4907, 2013.
  16. J. Y. Huh, et al., "FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise," Metabolism, vol. 61, pp. 1725–1738, 2012.
  17. W. W. Daniel dan C. L. Cross, Biostatistics: a foundation for analysis in the health sciences, Wiley, 2018.
  18. F. Martinon, A. Mayor, dan J. Tschopp, "The inflammasomes: guardians of the body," Annu. Rev. Immunol., vol. 27, pp. 229–265, 2009.
  19. W. J. Martin, O. Shaw, X. Liu, S. Steiger, dan J. L. Harper, "Monosodium urate monohydrate crystal–recruited noninflammatory monocytes differentiate into M1‐like proinflammatory macrophages in a peritoneal murine model of gout," Arthritis Rheum., vol. 63, pp. 1322–1332, 2011.
  20. C. A. Agudelo dan C. M. Wise, "Gout: diagnosis, pathogenesis, and clinical manifestations," Curr. Opin. Rheumatol., vol. 13, pp. 234–239, 2001.
  21. L. Spel dan F. Martinon, "Inflammasomes contributing to inflammation in arthritis," Immunol. Rev., vol. 294, pp. 48–62, 2020.
  22. P. Boström, et al., "A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis," Nature, vol. 481, pp. 463–468, 2012.
  23. S. Kajimura dan M. Saito, "A new era in brown adipose tissue biology: molecular control of brown fat development and energy homeostasis," Annu. Rev. Physiol., vol. 76, pp. 225–249, 2014.
  24. A. Stengel, et al., "Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity–correlation with body mass index," Peptides, vol. 39, pp. 125–130, 2013.
  25. S. Blüher, et al., "Effects of a 1‐year exercise and lifestyle intervention on irisin, adipokines, and inflammatory markers in obese children," Obesity, vol. 22, pp. 1701–1708, 2014.
  26. B. Yan, et al., "Association of serum irisin with metabolic syndrome in obese Chinese adults," PLoS One, vol. 9, p. e94235, 2014.
  27. S. Jäger, C. Handschin, J. St.-Pierre, dan B. M. Spiegelman, "AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α," Proc. Natl. Acad. Sci., vol. 104, pp. 12017–12022, 2007.
  28. S. Jang, K. Lee, dan J. H. Ju, "Recent updates of diagnosis, pathophysiology, and treatment on osteoarthritis of the knee," Int. J. Mol. Sci., vol. 22, p. 2619, 2021.
  29. L. Kalichman dan E. Kobyliansky, "Radiographic hand osteoarthritis and serum levels of osteocalcin: cross-sectional study," Rheumatol. Int., vol. 30, pp. 1131–1135, 2010.
  30. J. N. Katz, K. R. Arant, dan R. F. Loeser, "Diagnosis and treatment of hip and knee osteoarthritis: a review," Jama, vol. 325, pp. 568–578, 2021.
  31. A. Palermo, et al., "Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity," Clin. Endocrinol. (Oxf)., vol. 82, pp. 615–619, 2015.
  32. Y. Zhang, et al., "Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling," Diabetes, vol. 63, pp. 514–525, 2014.
  33. S. L. Dun, et al., "Irisin-immunoreactivity in neural and non-neural cells of the rodent," Neuroscience, vol. 240, pp. 155–162, 2013.
  34. D. Löffler, et al., "Serum irisin levels are regulated by acute strenuous exercise," J. Clin. Endocrinol. Metab., vol. 100, pp. 1289–1299, 2015.


Download data is not yet available.